BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11550094)

  • 21. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.
    Li P; Nijhawan D; Budihardjo I; Srinivasula SM; Ahmad M; Alnemri ES; Wang X
    Cell; 1997 Nov; 91(4):479-89. PubMed ID: 9390557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel Apaf-1-independent putative caspase-2 activation complex.
    Read SH; Baliga BC; Ekert PG; Vaux DL; Kumar S
    J Cell Biol; 2002 Dec; 159(5):739-45. PubMed ID: 12460989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1.
    Kim HE; Du F; Fang M; Wang X
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17545-50. PubMed ID: 16251271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the apoptotic protease-activating factor 1 bound to ADP.
    Riedl SJ; Li W; Chao Y; Schwarzenbacher R; Shi Y
    Nature; 2005 Apr; 434(7035):926-33. PubMed ID: 15829969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of WD2 subdomain of Apaf-1 forms an apoptosome structure which blocks activation of caspase-3 and caspase-9.
    Noori AR; Tashakor A; Nikkhah M; Eriksson LA; Hosseinkhani S; Fearnhead HO
    Biochimie; 2021 Jan; 180():23-29. PubMed ID: 33132160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9.
    Zou H; Li Y; Liu X; Wang X
    J Biol Chem; 1999 Apr; 274(17):11549-56. PubMed ID: 10206961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nucleotide binding site in caspase-9 regulates apoptosome activation.
    Chereau D; Zou H; Spada AP; Wu JC
    Biochemistry; 2005 Apr; 44(13):4971-6. PubMed ID: 15794635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance.
    Liu JR; Opipari AW; Tan L; Jiang Y; Zhang Y; Tang H; Nuñez G
    Cancer Res; 2002 Feb; 62(3):924-31. PubMed ID: 11830553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1.
    Jiang X; Wang X
    J Biol Chem; 2000 Oct; 275(40):31199-203. PubMed ID: 10940292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90.
    Pandey P; Saleh A; Nakazawa A; Kumar S; Srinivasula SM; Kumar V; Weichselbaum R; Nalin C; Alnemri ES; Kufe D; Kharbanda S
    EMBO J; 2000 Aug; 19(16):4310-22. PubMed ID: 10944114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity.
    Wolf BB; Schuler M; Li W; Eggers-Sedlet B; Lee W; Tailor P; Fitzgerald P; Mills GB; Green DR
    J Biol Chem; 2001 Sep; 276(36):34244-51. PubMed ID: 11429402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diarylurea compounds inhibit caspase activation by preventing the formation of the active 700-kilodalton apoptosome complex.
    Lademann U; Cain K; Gyrd-Hansen M; Brown D; Peters D; Jäättelä M
    Mol Cell Biol; 2003 Nov; 23(21):7829-37. PubMed ID: 14560026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.
    Srinivasula SM; Hegde R; Saleh A; Datta P; Shiozaki E; Chai J; Lee RA; Robbins PD; Fernandes-Alnemri T; Shi Y; Alnemri ES
    Nature; 2001 Mar; 410(6824):112-6. PubMed ID: 11242052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apo cytochrome c inhibits caspases by preventing apoptosome formation.
    Martin AG; Nguyen J; Wells JA; Fearnhead HO
    Biochem Biophys Res Commun; 2004 Jul; 319(3):944-50. PubMed ID: 15184073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 1.4-MDa apoptosome is a critical intermediate in apoptosome maturation.
    Beem E; Holliday LS; Segal MS
    Am J Physiol Cell Physiol; 2004 Sep; 287(3):C664-72. PubMed ID: 15128503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway.
    Genini D; Budihardjo I; Plunkett W; Wang X; Carrera CJ; Cottam HB; Carson DA; Leoni LM
    J Biol Chem; 2000 Jan; 275(1):29-34. PubMed ID: 10617581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the salt bridge between glutamate 546 and arginine 907 in preservation of autoinhibited form of Apaf-1.
    Shakeri R; Hosseinkhani S; Los MJ; Davoodi J; Jain MV; Cieślar-Pobuda A; Rafat M; Ardestani SK
    Int J Biol Macromol; 2015 Nov; 81():370-4. PubMed ID: 26277751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mathematical model for apoptosome assembly: the optimal cytochrome c/Apaf-1 ratio.
    Nakabayashi J; Sasaki A
    J Theor Biol; 2006 Sep; 242(2):280-7. PubMed ID: 16650876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new model for the transition of APAF-1 from inactive monomer to caspase-activating apoptosome.
    Reubold TF; Wohlgemuth S; Eschenburg S
    J Biol Chem; 2009 Nov; 284(47):32717-24. PubMed ID: 19801675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin-induced apoptosis in melanoma cells: role of caspase-3 and caspase-7 in Apaf-1 proteolytic cleavage and in execution of the degradative phases.
    Del Bello B; Valentini MA; Comporti M; Maellaro E
    Ann N Y Acad Sci; 2003 Dec; 1010():200-4. PubMed ID: 15033720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.